Freeline Therapeutics

Biotech

Syncona merges Freeline, SwanBio into new gene therapy biotech

Spur’s pipeline will feature Freeline’s Gaucher disease program FLT201, as well as SwanBio’s phase 1/2 program for adrenomyeloneuropathy.

James Waldron Jun 17, 2024 11:01am

Lifeline

Syncona throws lifeline to Freeline by buying struggling biotech

Nov 22, 2023 9:40am

runway takeoff airport cleared go

Freeline, facing fading cash runway, mulls buyout by Syncona

Oct 19, 2023 10:00am

fired layoffs cut executives dismissed

Freeline cans another 30% of its staff months after last layoffs

Apr 4, 2023 8:45am

bear market bull market stocks markets funding VC venture capital

Syncona blames biotech bear market for 'disappointing' returns

Feb 7, 2023 10:31am

Layoffs

Adamis, Harpoon, Neoleukin and Tricida grow biotech layoff wave

Nov 15, 2022 6:45am